Thus, some mechanistic overlap between CPVT and LQTS caused by CaM mutations likely exist, and how arrhythmogenic CaM mutations manifest probably depends on their relative effects on RyR2, CaV1.2, and other CaM-regulated targets. The gene discussed is CALM1; the disease is familial long QT syndrome.